Reexcízió és perioperatív brachyterápia az emlómegtartó mútét utáni lokális recidíva kezelésére: a mastectomia lehetséges alternatívája.

Translated title of the contribution: Reexcision and perioperative brachytherapy in the treatment of local relapse after breast conservation: a possible alternative to mastectomy

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Breast conserving surgery and postoperative radiotherapy became widely accepted in the last two decades for the treatment of early invasive breast cancer. In spite of adequate surgery and radiotherapy, the rate of ipsilateral breast tumor recurrence is approximately 10%. In such cases salvage mastectomy is the standard treatment, however wide reexcision of the recurrent tumor is also a reasonable option for selected patients. The risk of second local relapse is higher following further breast conservation compared to mastectomy. The authors report the technique of tumor reexcision combined with intraoperative implantation and perioperative high dose rate (HDR) bracytherapy of the tumor bed for the salvage of recurrence in a previously irradiated breast. One can perform two operative interventions at the same time with this method. Irradiation can be started safely within 48 hours after surgery. A review of the literature is also performed by the authors to demonstrate the role and indication of perioperative brachytherapy in the treatment of breast tumor relapse and other cancer recurrences. Reexcision is a practicable alternative to mastectomy for solitary, parenchymal breast tumor relapse measured 2 cm or less in diameter. Perioperative brachytherapy may decrease the risk of second relapse without increasing radiation side effects. Further prospective study is required to define the value of the prescribed method in comparison with salvage mastectomy.

Original languageHungarian
Pages (from-to)120-123
Number of pages4
JournalMagyar sebészet
Volume53
Issue number3
Publication statusPublished - 2000

Fingerprint

Mastectomy
Brachytherapy
Breast
Recurrence
Breast Neoplasms
Therapeutics
Neoplasms
Radiotherapy
Segmental Mastectomy
Radiation Effects
Prospective Studies

Cite this

@article{b118adcb69da4b90b96f4b9a1a1d86a7,
title = "Reexc{\'i}zi{\'o} {\'e}s perioperat{\'i}v brachyter{\'a}pia az eml{\'o}megtart{\'o} m{\'u}t{\'e}t ut{\'a}ni lok{\'a}lis recid{\'i}va kezel{\'e}s{\'e}re: a mastectomia lehets{\'e}ges alternat{\'i}v{\'a}ja.",
abstract = "Breast conserving surgery and postoperative radiotherapy became widely accepted in the last two decades for the treatment of early invasive breast cancer. In spite of adequate surgery and radiotherapy, the rate of ipsilateral breast tumor recurrence is approximately 10{\%}. In such cases salvage mastectomy is the standard treatment, however wide reexcision of the recurrent tumor is also a reasonable option for selected patients. The risk of second local relapse is higher following further breast conservation compared to mastectomy. The authors report the technique of tumor reexcision combined with intraoperative implantation and perioperative high dose rate (HDR) bracytherapy of the tumor bed for the salvage of recurrence in a previously irradiated breast. One can perform two operative interventions at the same time with this method. Irradiation can be started safely within 48 hours after surgery. A review of the literature is also performed by the authors to demonstrate the role and indication of perioperative brachytherapy in the treatment of breast tumor relapse and other cancer recurrences. Reexcision is a practicable alternative to mastectomy for solitary, parenchymal breast tumor relapse measured 2 cm or less in diameter. Perioperative brachytherapy may decrease the risk of second relapse without increasing radiation side effects. Further prospective study is required to define the value of the prescribed method in comparison with salvage mastectomy.",
author = "C. Polg{\'a}r and Z. Sulyok and T. Major and E. Riedl and A. Somogyi and J. Fodor and I. K{\"o}ves and G. N{\'e}meth",
year = "2000",
language = "Hungarian",
volume = "53",
pages = "120--123",
journal = "Magyar Sebeszet",
issn = "0025-0295",
publisher = "Ifjusagi Lapkiado Vallalat",
number = "3",

}

TY - JOUR

T1 - Reexcízió és perioperatív brachyterápia az emlómegtartó mútét utáni lokális recidíva kezelésére

T2 - a mastectomia lehetséges alternatívája.

AU - Polgár, C.

AU - Sulyok, Z.

AU - Major, T.

AU - Riedl, E.

AU - Somogyi, A.

AU - Fodor, J.

AU - Köves, I.

AU - Németh, G.

PY - 2000

Y1 - 2000

N2 - Breast conserving surgery and postoperative radiotherapy became widely accepted in the last two decades for the treatment of early invasive breast cancer. In spite of adequate surgery and radiotherapy, the rate of ipsilateral breast tumor recurrence is approximately 10%. In such cases salvage mastectomy is the standard treatment, however wide reexcision of the recurrent tumor is also a reasonable option for selected patients. The risk of second local relapse is higher following further breast conservation compared to mastectomy. The authors report the technique of tumor reexcision combined with intraoperative implantation and perioperative high dose rate (HDR) bracytherapy of the tumor bed for the salvage of recurrence in a previously irradiated breast. One can perform two operative interventions at the same time with this method. Irradiation can be started safely within 48 hours after surgery. A review of the literature is also performed by the authors to demonstrate the role and indication of perioperative brachytherapy in the treatment of breast tumor relapse and other cancer recurrences. Reexcision is a practicable alternative to mastectomy for solitary, parenchymal breast tumor relapse measured 2 cm or less in diameter. Perioperative brachytherapy may decrease the risk of second relapse without increasing radiation side effects. Further prospective study is required to define the value of the prescribed method in comparison with salvage mastectomy.

AB - Breast conserving surgery and postoperative radiotherapy became widely accepted in the last two decades for the treatment of early invasive breast cancer. In spite of adequate surgery and radiotherapy, the rate of ipsilateral breast tumor recurrence is approximately 10%. In such cases salvage mastectomy is the standard treatment, however wide reexcision of the recurrent tumor is also a reasonable option for selected patients. The risk of second local relapse is higher following further breast conservation compared to mastectomy. The authors report the technique of tumor reexcision combined with intraoperative implantation and perioperative high dose rate (HDR) bracytherapy of the tumor bed for the salvage of recurrence in a previously irradiated breast. One can perform two operative interventions at the same time with this method. Irradiation can be started safely within 48 hours after surgery. A review of the literature is also performed by the authors to demonstrate the role and indication of perioperative brachytherapy in the treatment of breast tumor relapse and other cancer recurrences. Reexcision is a practicable alternative to mastectomy for solitary, parenchymal breast tumor relapse measured 2 cm or less in diameter. Perioperative brachytherapy may decrease the risk of second relapse without increasing radiation side effects. Further prospective study is required to define the value of the prescribed method in comparison with salvage mastectomy.

UR - http://www.scopus.com/inward/record.url?scp=0034208389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034208389&partnerID=8YFLogxK

M3 - Article

C2 - 11299499

AN - SCOPUS:0034208389

VL - 53

SP - 120

EP - 123

JO - Magyar Sebeszet

JF - Magyar Sebeszet

SN - 0025-0295

IS - 3

ER -